KEY POINTS In most medical subspecialties, genetic and genomic testing have become a routine part of clinical care. However, access to genetic testing at the patient, provider, and provincial levels is inequitable, with varying approval processes and public funding and, consequently, differences in
No takes yet. Share an insight, caveat, or question.
Bartels et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: